N-Carbamoyl-L-aspartate (BioCAD00000014636)

feces prostate tissue saliva prostate

Metabolite Card

Formula: C5H8N2O5 (176.0433)
SMILES: NC(=O)N[C@@H](CC(O)=O)C(O)=O

Synonyms [en]

N-carbamoyl-L-aspartate; N-carbamoyl-L-aspartic acid; N-(aminocarbonyl)-L-aspartic acid; L-Ureidosuccinic acid; (2S)-2-(carbamoylamino)butanedioic acid; N-carbamoylaspartate

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

N-Carbamoyl-L-aspartate. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000014636). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Ureidosuccinic acid, also known as L-ureidosuccinate or carbamyl-L-aspartate, belongs to the class of organic compounds known as aspartic acids and derivatives. Aspartic acids and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Ureidosuccinic acid is also classified as a carbamate derivative. It is a solid that is soluble in water. Ureidosuccinic acid exists in all living species, ranging from bacteria to plants to humans. Ureidosuccinic acid can be biosynthesized from carbamoyl phosphate and L-aspartic acid through the action of the enzyme known as aspartate carbamoyltransferase (ACTase) and serves as an intermediate in pyrimidine biosynthesis. In humans, a drop in the level of urinary ureidosuccinic acid is associated with bladder cancer (PMID: 25562196). It is also involved in the metabolic disorder called Canavan disease.

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 13184-27-5
  • CAS Registry Number: 923-37-5
  • PubChem: 279
  • PubChem: 3727
  • PubChem: 93072
  • ChEBI: ChEBI:15859
  • ChEBI: ChEBI:64850
  • HMDB: HMDB0000828
  • KEGG: C00438
  • NCBI MeSH: ureidosuccinic acid
  • Wikipedia: Carbamoyl_aspartic_acid
  • DrugBank: DB04252
  • RefMet: RM0037601
  • RefMet: RM0128765
  • MoNA: FiehnLib000406
  • MoNA: FiehnLib000407
  • MoNA: GLS00112
  • MoNA: KO000411
  • MoNA: KO000412
  • MoNA: KO000413
  • MoNA: KO000414
  • MoNA: KO000415
  • MoNA: OUF00384
  • MoNA: PR100879
  • MoNA: PS104801
  • MoNA: PS104802
  • MoNA: PS104803
  • MoNA: PS104807
  • MoNA: PS104808
  • Metlin: METLIN_3304
  • Coconut NaturalProduct: CNP0396749.1

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R00484 3.5.1.7 N-carbamoyl-L-aspartate amidohydrolase
KEGG:R01397 2.1.3.2 carbamoyl-phosphate:L-aspartate carbamoyltransferase
KEGG:R01993 3.5.2.3 (S)-dihydroorotate amidohydrolase
KEGG:R02284 3.5.2.4 L-5-carboxymethylhydantoin amidohydrolase
View More
Organism Source

Taxonomy Source

  1. Arabidopsis thaliana [ncbi taxid: 3702]
  2. Escherichia coli [ncbi taxid: 562]

Pathway Synthetic

pathway id name
BioCyc:TRYPANO_PRPP-PWY superpathway of histidine, purine, and pyrimidine biosynthesis
BioCyc:LEISH_PWY-5686 uridine-5'-phosphate biosynthesis
BioCyc:TRYPANO_PWY-5686 uridine-5'-phosphate biosynthesis
BioCyc:LEISH_PWY0-162 pyrimidine ribonucleotides de novo biosynthesis
BioCyc:TRYPANO_PWY0-162 pyrimidine ribonucleotides de novo biosynthesis
WikiPathways:WP3604 Biochemical pathways: part I
WikiPathways:WP662 Amino acid metabolism
WikiPathways:WP106 Alanine and aspartate metabolism
WikiPathways:WP4022 Pyrimidine metabolism
WikiPathways:WP3262 Alanine and aspartate metabolism
WikiPathways:WP3925 Amino acid metabolism
PathBank:SMP0120678 beta-Ureidopropionase Deficiency
PathBank:SMP0120722 Hypoacetylaspartia
PathBank:SMP0120750 MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)
PathBank:SMP0000178 Dihydropyrimidinase Deficiency
PathBank:SMP0087165 Aspartate Metabolism
PathBank:SMP0087426 Aspartate Metabolism
PathBank:SMP0120681 Canavan Disease
PathBank:SMP0120693 Dihydropyrimidinase Deficiency
PathBank:SMP0120507 UMP Synthase Deficiency (Orotic Aciduria)
View All Pathways